NCNANuCana plc

Nasdaq nucana.com


$ 3.58 $ 0.14 (4.06 %)    

Wednesday, 22-May-2024 15:59:33 EDT
QQQ $ 454.82 $ -2.72 (-0.59 %)
DIA $ 398.57 $ -2.73 (-0.69 %)
SPY $ 530.36 $ -2.54 (-0.48 %)
TLT $ 91.26 $ -0.79 (-0.86 %)
GLD $ 225.37 $ -2.09 (-0.95 %)
$ 3.59
$ 3.60
$ 0.00 x 0
$ 0.00 x 0
$ 3.47 - $ 3.60
$ 3.40 - $ 23.75
14,614
na
7.59M
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nucana-regains-compliance-with-nasdaq-minimum-bid-price-requirement

NuCana plc (NASDAQ:NCNA), ("NuCana" or the "Company"), announced that it has received a written notification (t...

 nucana-announces-completion-of-1-for-25-ads-ratio-change

NuCana plc (NASDAQ:NCNA) announced that the Company's previously disclosed plans to change the ratio of its American Deposi...

 oppenheimer-reiterates-outperform-on-nucana-maintains-4-price-target

Oppenheimer analyst Leland Gershell reiterates NuCana (NASDAQ:NCNA) with a Outperform and maintains $4 price target.

 why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

 why-nucana-ncna-shares-are-trading-lower

NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust th...

 why-rh-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

 nucana-announces-plan-to-implement-1-for-25-ads-ratio-change

NuCana plc (NASDAQ:NCNA) announced plans to change the ratio of its American Depository Shares ("ADSs") to its ordinary...

 nucana-q4-earnings-insights
NuCana: Q4 Earnings Insights
03/20/2024 21:40:06

 nucana-filed-us-patent-application-20240082287	formulations-of-phosphoramidate-derivatives-of-nucleoside-drugs

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240082287

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION